• Ga direct naar: inhoud, service menu, zoeken
HomepageHomepage
Answers for Business: finding your way in Dutch rules, permits and subsidies
  • Home
  • Subjects
  • Sectors
  • Subsidies
  • Taxes
  • Advanced search
  • Sitemap

Home›Regulation›

Medicinal products research

Before you are allowed to market a medicine in the Netherlands, you must conduct research or arrange for research to be conducted to test that medicine. If this research comes under the Medical Research (Human Subjects) Act (Wet medisch-wetenschappelijk onderzoek met mensen, WMO) or the Embryos Act (Embryowet), you must first submit the research protocol to a recognised medical ethics review committee (METC). The Central Committee on Research Involving Human Subjects (CCMO) can supply you a list of all METC's. The research cannot go ahead without the committee’s approval.

In addition, medicinal products research often has to be submitted to the Central Committee on Research Involving Human Subjects (CCMO) or to the Ministry of Health, Welfare and Sport (VWS) who will carry out an additional, marginal assessment.

Links

Questions?

  • Please contact Answers for Business

External links

  • Contact (Central Committee on Research Involving Human Subjects) (Dutch)
  • Contact (Ministry of Health, Welfare and Sport)

Related links

    • Trading permit for medicines
    • Patient information leaflet
Related tags: Product development, Product safety
Go to top
Service menu
  • Contact
  • Nederlands
  • Mobile
Rijksoverheid footer
  • Copyright
share